Prevalence of dyslipidemia and prediction of 10-year CVD risk among older adults living in southeast coastal regions in China: a cross-sectional study

References

• Fuster V. Changing demographics: a new approach to global health care due to the aging population. J Am Coll Cardiol. 2017;69:3002–3005. doi:10.1016/j.jacc.2017.05.01328619199
   PubMed Web of Science ®Google Scholar
• Wu Y, Benjamin EJ, MacMahon S. Prevention and control of cardiovascular disease in the rapidly changing economy of china. Circulation. 2016;133:2545–2560. doi:10.1161/CIRCULATIONAHA.115.00872827297347
   PubMed Web of Science ®Google Scholar
• Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139-146.
   Google Scholar
• Yang W, Xiao J, Yang Z, et al. China National Diabetes and Metabolic Disorders Study investigators. Serum lipids and lipoproteins in Chinese men and women. Circulation. 2012;125:2212–2221. doi:10.1161/CIRCULATIONAHA.111.06590422492668
   PubMed Web of Science ®Google Scholar
• Wu J, Cheng X, Qiu L, et al. Prevalence and clustering of major cardiovascular risk factors in china: a recent cross-sectional survey. Medicine (Baltimore). 2016;95:e2712. doi:10.1097/MD.000000000000486426962771
   PubMed Web of Science ®Google Scholar
• Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: A nationally representative survey of 163,641 adults. Int J Cardiol. 2018;260:196–203. doi:10.1016/j.ijcard.2017.12.06929622441
   PubMed Web of Science ®Google Scholar
• Chen GY, Li L, Dai F, Li XJ, Xu XX, Fan JG. Prevalence and risk factors for type 2 diabetes mellitus in hyperlipidemia in China. Med Sci Monit. 2015;21:2476–2484. doi:10.12659/MSM.89424626297334
   PubMed Web of Science ®Google Scholar
• Pan L, Yang Z, Wu Y, et al. China National Survey of Chronic Kidney Disease Working Group. The prevalence, awareness, treatment and control of dyslipidemia among adults in China. Atherosclerosis. 2016;248:2–9. doi:10.1016/j.atherosclerosis.2016.02.00626978581
   PubMed Web of Science ®Google Scholar
• Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847.9603539
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu X, Li X, et al. USA-PRC collaborative study of cardiovascular and cardiopulmonary epidemiology research group; China multicenter collaborative study of cardiovascular epidemiology research group. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006;114:2217–2225. doi:10.1161/CIRCULATIONAHA.105.60749917088464
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935–2959. doi:10.1016/j.jacc.2013.11.00524239921
   PubMed Web of Science ®Google Scholar
• Zhang M, Jiang Y, Wang LM, et al. 2010 China Non-communicable disease surveillance group. prediction of 10-year atherosclerotic cardiovascular disease risk among adults aged 40-79 years in China: a nationally representative survey. Biomed Environ Sci. 2017;30:244–254. doi:10.3967/bes2017.03428494834
   PubMed Web of Science ®Google Scholar
• Chia YC, Lim HM, Ching SM. Validation of the pooled cohort risk score in an Asian population – a retrospective cohort study. BMC Cardiovasc Disord. 2014;14:163. doi:10.1186/1471-2261-14-16325410585
   PubMed Web of Science ®Google Scholar
• Joint committee issued Chinese guideline for the management of dyslipidemia in adults. [2016 Chinese guideline for the management of dyslipidemia in adults]. Zhonghua Xin Xue Guan Bing Za Zhi. 2016;44:833–853. doi:10.3760/cma.j.issn.0253-3758.2016.10.00527903370
   PubMedGoogle Scholar
• Stone NJ, Robinson JG, Lichtenstein AH, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2889–2934. doi:10.1016/j.jacc.2013.11.00224239923
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology of Chinese Medical Association, editorial board of Chinese Journal of Cardiology. [Chinese guidelines for prevention of cardiovascular diseases]. Zhonghua Xin Xue Guan Bing Za Zhi. 2011;39(1):3–22.21418789
   PubMedGoogle Scholar
• Zhang FL, Xing YQ, Wu YH, et al. The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey. Lipids Health Dis. 2017;16:61. doi:10.1186/s12944-017-0565-828330492
   PubMed Web of Science ®Google Scholar
• Ni WQ, Liu XL, Zhuo ZP, et al. Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen. Lipids Health Dis. 2015;14:71. doi:10.1186/s12944-015-0073-726168792
   PubMed Web of Science ®Google Scholar
• Zhong Z, Liu J, Li B, et al. Serum lipid profiles in patients with acute myocardial infarction in Hakka population in southern China. Lipids Health Dis. 2017;16:246. doi:10.1186/s12944-017-0565-829246160
   PubMed Web of Science ®Google Scholar
• Bayram F, Kocer D, Gundogan K, et al. Prevalence of dyslipidemia and associated risk factors in Turkish adults. J Clin Lipidol. 2014;8:206–216. doi:10.1016/j.jacl.2013.12.01124636181
   PubMed Web of Science ®Google Scholar
• Stein EA, Raal FJ. Targeting LDL: is lower better and is it safe? Best Pract Res Clin Endocrinol Metab. 2014;28:309–324. doi:10.1016/j.beem.2013.10.01024840261
   PubMed Web of Science ®Google Scholar
• Feng RN, Zhao C, Wang C, et al. BMI is strongly associated with hypertension, and waist circumference is strongly associated with type 2 diabetes and dyslipidemia in northern Chinese adults. J Epidemiol. 2012;22:317–323.22672914
   PubMed Web of Science ®Google Scholar
• Zhu Y, Shao Z, Jing J, et al. Body mass index is better than other anthropometric indices for identifying dyslipidemia in Chinese children with obesity. PLoS One. 2016;11:e0149392. doi:10.1371/journal.pone.014939226963377
   PubMed Web of Science ®Google Scholar
• Gu D, He J, Duan X, et al. Body weight and mortality among men and women in China. Jama. 2006;295:776–783. doi:10.1001/jama.295.7.77616478900
   PubMed Web of Science ®Google Scholar
• Zhang M, Huang ZJ, Li YC, Wang LM, Jiang Y, Zhao WH. For working group of China chronic disease surveillance(2010). Prediction of 10-year risk for ischemic cardiovascular disease in adults aged ≥35 years in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2016;37(5):689–693. In Chinese. doi:10.3760/cma.j.issn.0254-6450.2016.05.02127188364
   PubMedGoogle Scholar